Clinical Trial Update: Composition for Treating Spermatogenesis and Semen Disorders / FPT-20 [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (NCT05399212) evaluating a composition called FPT-20 for spermatogenesis and semen disorders has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spermatogenesis and Semen Disorders

Drugs mentioned

• FPT-20

Snippet

Sponsor: Trieu, Nguyen Thi, M.D. | Conditions: Spermatogenesis and Semen Disorders | Phase 4 | Status: COMPLETED